Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | CTSV | O60911 | 1/20 | 0.55 |
| ▸ | CTSL | P07711 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30322798 | 1.00 | ALDH1A1 (0.69) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL8410965 | 0.98 | ALDH1A1 (0.67) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL27673644 | 0.98 | ALDH1A1 (0.67) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL27653666 | 0.98 | ALDH1A1 (0.67) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL27673750 | 0.98 | ALDH1A1 (0.67) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL6393919 | 0.98 | ALDH1A1 (0.67) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| Potassium Ion SCHEMBL8410957 | 0.96 | ALDH1A1 (0.65) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL27129636 | 0.86 | L3MBTL1 (0.67) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| Aminobenzoic Acid SCHEMBL11348031 | 0.86 | TDP1 (0.56) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 | |
| SCHEMBL4829731 | 0.86 | TDP1 (0.66) | ALDH1A1TDP1SMN1; SMN2L3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1722 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12533430-B2 | Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2026-01-27 | — | — | US | claimed |
| US-12529648-B2 | Colored reagent complex and method of detecting a rust removing agent in metal working fluids using the same | NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION (US) | 2026-01-20 | — | — | US | claimed |
| EP-4082580-B1 | CARBON MICROBEAD LOADED WITH METAL NUCLIDE, PREPARATION METHOD, AND APPLICATION | CHENGDU NEW RADIOMEDICINE TECH CO LTD (CN) | 2025-09-10 | — | — | EP | claimed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| CN-119930435-A | Preparation method of mesalamine intermediate | 珠海润都制药股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119613346-A | Method for preparing 5-bromopyrimidine | 上海沃缨生物科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | claimed |
| EP-3946461-B1 | XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF | UNIV BRITISH COLUMBIA (CA) | 2025-01-15 | — | — | EP | claimed |
| CN-119241604-A | Organic-inorganic hybrid { Ti3In}xCrystalline state titanium indium oxide cluster patterning material and preparation method and application thereof | 中国科学院福建物质结构研究所 | 2025-01-03 | — | — | CN | claimed |
| EP-4112085-B1 | VISUALIZED RADIOACTIVE CARBON MICROSPHERE, AND PREPARATION METHOD AND APPLICATION THEREOF | CHENGDU NEW RADIOMEDICINE TECH CO LTD (CN) | 2024-12-11 | — | — | EP | claimed |
| CN-1132197-A | 3,3'-azo-bi-(6-hydroxy benzoic acid) | SHANGHAI CHINESE AND WESTERN M (CN) | 1996-10-02 | — | — | CN | claimed |
| EP-0519971-A1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE. | EEC PHARMA SA (FR) | 1992-12-30 | — | — | EP | claimed |
| WO-1991013886-A1 | NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE | EEC-PHARMA S.A. (FR) | 1991-09-19 | — | — | WO | claimed |
| US-4837229-A | ANTIINFLAMMATORY AGENTS IN GASTROINTESTINAL TRACT | HENNING BERLIN GMBH CHEMIE- UND PHARMAWERK (DE) | 1989-06-06 | — | — | US | claimed |
| WO-1988009398-A1 | ELECTROCHEMICAL SYNTHESIS OF SUBSTITUTED AMINES IN BASIC MEDIA | THE DOW CHEMICAL COMPANY (US) | 1988-12-01 | — | — | WO | claimed |
| EP-0291865-A2 | Electrochemical synthesis of substituted aromatic amines in basic media | THE DOW CHEMICAL COMPANY (US) | 1988-11-23 | — | — | EP | claimed |
| US-4764263-A | Electrochemical synthesis of substituted aromatic amines in basic media | THE DOW CHEMICAL COMPANY (US) | 1988-08-16 | — | — | US | claimed |
| US-4302521-A | TRANSPORT PHASE OF A P-TYPE ORGANIC SEMICONDUCTOR, POLYVINYLCARBAZOLE, A LEWIS AND A BRONSTED ACID; CHARGE TRANSFER COMPOUNDS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-11-24 | — | — | US | claimed |
| US-4025609-A | CHELATION | KAO SOAP CO., LTD. (JA) | 1977-05-24 | — | — | US | claimed |
| US-3997342-A | Photoconductive element exhibiting persistent conductivity | EASTMAN KODAK COMPANY (US) | 1976-12-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533430-B2 | Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof | CPS1, SRM, NES | ALDH1A1 1172/4885TDP1 3323/4885SMN1; SMN2 1730/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | ALDH1A1 699/4885TDP1 4141/4885SMN1; SMN2 4516/4885 |
| US-12529648-B2 | Colored reagent complex and method of detecting a rust removing agent in metal working fluids using the same | TST, RUVBL1, RUVBL2 | ALDH1A1 1316/4885TDP1 4453/4885SMN1; SMN2 2972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.